Important Information Affecting Patients Prescribed LANTUS (Insulin glargine 100 units/mL)
A Message from Sanofi Sanofi would like to reassure you and patients with insulin-dependent diabetes that we are not experiencing any shortages of insulin glargine 100 units/mL in Australia as aresult of the COVID-19 pandemic. Sanofi has accelerated its supply of Optisulin (insulin glargine100 units/mL) in Australia to support the ongoing availability of insulin glargine…